July 18, 2022

Understanding Project Optimus

The FDA’s Oncology Center of Excellence has launched an initiative to reform the dose optimization and dose selection paradigm in oncology drug development. Known as Project Optimus, this initiative recommends a core change in how doses are selected during oncology clinical trials and post-approval studies.

Sirj Goswami, PhD, CEO, co-founder of InsightRX and Jason Rizzo, MBA, VP Global Biopharma Strategy discuss this topic in more detail in an article published by Applied Clinical Trials*.

Click here to read the full article.

Read Full Article
Filter By:

Apply Filters

Category
No resource was found.
The Evolution of Therapeutic Drug Monitoring for Tacrolimus
September 07, 2022

The Evolution of Therapeutic Drug Monitoring for Tacrolimus

Learn More
Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy
August 09, 2022

Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy

Learn More
InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC 
July 25, 2022

InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC 

Learn More
InsightRX Helps Boone County Hospital Improve Patient Safety with Precision Dosing
June 01, 2022

InsightRX Helps Boone County Hospital Improve Patient Safety with Precision Dosing

Learn More
Understanding FDA’s Perspective On Precision Dosing
April 06, 2022

Understanding FDA’s Perspective On Precision Dosing

Learn More
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
April 05, 2022

Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing

Learn More
InsightRX Reports Record Growth In Platform Adoption By Health Systems And Biopharma Companies
March 28, 2022

InsightRX Reports Record Growth In Platform Adoption By Health Systems And Biopharma Companies

Learn More
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
March 27, 2022

Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation

Learn More
Model-Based Tacrolimus Follow-Up Dosing in Adult Renal Transplant Recipients: A Simulation Trial.
March 25, 2022

Model-Based Tacrolimus Follow-Up Dosing in Adult Renal Transplant Recipients: A Simulation Trial.

Learn More
Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
March 24, 2022

Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas

Learn More